These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 501898)

  • 1. Escape from sodium and potassium retaining actions of aspirin-like drugs used in a patient with Bartter's syndrome.
    Ishikawa Y; Wada T
    Jpn Circ J; 1979 Aug; 43(8):757-67. PubMed ID: 501898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic studies in Bartter's syndrome: opposite effects of treatment with antikaliuretic and antiprostaglandin drugs. Part I.
    Simatupang TA; Radó JP; Boer P; Geyskes GG; Vos J; Dorhout Mees EJ
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):14-8. PubMed ID: 631965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A
    Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins and aspirin therapy in Bartter's syndrome.
    Norby L; Flamenbaum W; Lentz R; Ramwell P
    Lancet; 1976 Sep; 2(7986):604-6. PubMed ID: 61344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the pathogenesis of Bartter's syndrome.
    Baehler RW; Work J; Kotchen TA; McMorrow G; Guthrie G
    Am J Med; 1980 Dec; 69(6):933-8. PubMed ID: 7446558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 7. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
    Gill JR; Frölich JC; Bowden RE; Taylor AA; Keiser HR; Seyberth HW; Oates JA; Bartter FC
    Am J Med; 1976 Jul; 61(1):43-51. PubMed ID: 820194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride.
    Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Yoshinaga K; Saito T; Kabuki J
    Tohoku J Exp Med; 1980 Jun; 131(2):151-9. PubMed ID: 7404582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ; de Jong PE; van Eps LW; Brentjens JR; Bakker K; Doorenbos H
    Nephron; 1977; 19(4):200-13. PubMed ID: 917167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Bartter's syndrome with indomethacin.
    Garin EH; Fennell RS; Iravani A; Richard GA
    Am J Dis Child; 1980 Mar; 134(3):258-61. PubMed ID: 6767392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
    JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bartter's syndrome. Failure of aspirin and success of indomethacin].
    Jáuregui WO; Di Fonzo P; Marchissio ML; Roehr E; Hauger-Klevene JH
    Medicina (B Aires); 1979; 39(4):447-56. PubMed ID: 397398
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K; Schreiber V; Dvoráková J
    Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bartter's syndrome with normal chloride reabsorption during indomethacin treatment.
    Hornych A; Huet de Barochez Y; Bariéty J; Branca GF; Vigeral P; Girard JF; Kazatchkine M; De Gennes JL; Truffert J; Bocquet L
    Nephron; 1987; 46(2):137-43. PubMed ID: 3600922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic Bartter's syndrome.
    Barbour GL; Day JO
    South Med J; 1978 Nov; 71(11):1341-4, 1349. PubMed ID: 715482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the pathogenetic role of prostaglandins in Bartter's syndrome.
    Nielsen I; Hesse B; Christensen P
    Acta Med Scand Suppl; 1979; 625():135-40. PubMed ID: 285569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors.
    Littlewood JM; Lee MR; Meadow SR
    Arch Dis Child; 1978 Jan; 53(1):43-8. PubMed ID: 415668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle electrolytes and fluid compartments in six children with Bartter's syndrome.
    Delaporte C; Stulzaft J; Loirat C; Broyer M
    Clin Sci Mol Med; 1978 Mar; 54(3):223-31. PubMed ID: 630799
    [No Abstract]   [Full Text] [Related]  

  • 19. Bartter's syndrome--observations on the pathophysiology.
    Solomon LR; Bobinski H; Astley P; Goldby FS; Mallick NP
    Q J Med; 1982; 51(203):251-70. PubMed ID: 7146310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors.
    Rudin A; Aurell M; Hansson L; Westberg G
    Scand J Clin Lab Invest; 1979 Oct; 39(6):543-50. PubMed ID: 119300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.